Kamran Kadkhoda1, Cecilia Dumouchel1, Janna Brancato1, Ainsley Gretchen1, Peter J Krause1. 1. Affiliations: Cadham Provincial Laboratory (Kadkhoda, Gretchen); Departments of Medical Microbiology & Infectious Diseases and Immunology (Kadkhoda), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Man.; Yale School of Public Health (Dumouchel, Brancato, Krause); Yale School of Medicine (Krause), New Haven, CT.
Abstract
BACKGROUND: Hard tick-borne relapsing fever caused by Borrelia miyamotoi has been reported in Russia, the Netherlands, Germany, Japan and the northeastern and upper midwestern United States. We sought to investigate the presence of B. miyamotoi infection in humans in Manitoba, Canada. METHODS: Two hundred fifty sera collected from residents of Manitoba with suspected Lyme disease between 2011 and 2014 were tested for Borrelia burgdorferi antibody using a C6 peptide enzyme-linked immunosorbent assay (ELISA) followed by Western blot. Residual sera were then anonymized, stored at -80°C and subsequently thawed and tested for B. miyamotoi antibody using a 2-step glycerosphosphodiester phosphodiesterase-based ELISA and Western blot assay. RESULTS: Twenty-four of the 250 (9.6%) sera tested positive for B. miyamotoi immunoglobulin G. Participants who were B. miyamotoi seropositive were predominantly male (54%) and younger on average than those who were seronegative (32 and 44 yr of age, respectively). Participants who were seropositive for B. burgdorferi were significantly more likely to be B. miyamotoi seropositive than those who were B. burgdorferi seronegative (20.3% v. 6.6%, respectively, odds ratio 3.6, 95% confidence interval 1.5-8.5). INTERPRETATION: This initial report of human B. miyamotoi infection in Canada should raise awareness of hard tick-borne relapsing fever among clinicians and residents of areas in Canada and western North America where Lyme disease is endemic. Copyright 2017, Joule Inc. or its licensors.
BACKGROUND: Hard tick-borne relapsing fever caused by Borrelia miyamotoi has been reported in Russia, the Netherlands, Germany, Japan and the northeastern and upper midwestern United States. We sought to investigate the presence of B. miyamotoiinfection in humans in Manitoba, Canada. METHODS: Two hundred fifty sera collected from residents of Manitoba with suspected Lyme disease between 2011 and 2014 were tested for Borrelia burgdorferi antibody using a C6 peptide enzyme-linked immunosorbent assay (ELISA) followed by Western blot. Residual sera were then anonymized, stored at -80°C and subsequently thawed and tested for B. miyamotoi antibody using a 2-step glycerosphosphodiester phosphodiesterase-based ELISA and Western blot assay. RESULTS: Twenty-four of the 250 (9.6%) sera tested positive for B. miyamotoi immunoglobulin G. Participants who were B. miyamotoi seropositive were predominantly male (54%) and younger on average than those who were seronegative (32 and 44 yr of age, respectively). Participants who were seropositive for B. burgdorferi were significantly more likely to be B. miyamotoi seropositive than those who were B. burgdorferi seronegative (20.3% v. 6.6%, respectively, odds ratio 3.6, 95% confidence interval 1.5-8.5). INTERPRETATION: This initial report of humanB. miyamotoiinfection in Canada should raise awareness of hard tick-borne relapsing fever among clinicians and residents of areas in Canada and western North America where Lyme disease is endemic. Copyright 2017, Joule Inc. or its licensors.
Authors: Alan G Barbour; Jonas Bunikis; Bridgit Travinsky; Anne Gatewood Hoen; Maria A Diuk-Wasser; Durland Fish; Jean I Tsao Journal: Am J Trop Med Hyg Date: 2009-12 Impact factor: 2.345
Authors: Philip J Molloy; Sam R Telford; Hanumara Ram Chowdri; Timothy J Lepore; Joseph L Gugliotta; Karen E Weeks; Mary Ellen Hewins; Heidi K Goethert; Victor P Berardi Journal: Ann Intern Med Date: 2015-07-21 Impact factor: 25.391
Authors: Peter J Krause; Sukanya Narasimhan; Gary P Wormser; Lindsay Rollend; Erol Fikrig; Timothy Lepore; Alan Barbour; Durland Fish Journal: N Engl J Med Date: 2013-01-17 Impact factor: 91.245
Authors: Alexander E Platonov; Ludmila S Karan; Nadezhda M Kolyasnikova; Natalya A Makhneva; Marina G Toporkova; Victor V Maleev; Durland Fish; Peter J Krause Journal: Emerg Infect Dis Date: 2011-10 Impact factor: 6.883
Authors: Daniel J Salkeld; Nathan C Nieto; Patricia Carbajales-Dale; Michael Carbajales-Dale; Stephanie S Cinkovich; Eric F Lambin Journal: PLoS One Date: 2015-08-19 Impact factor: 3.240
Authors: Seungeun Han; Charles Lubelczyk; Graham J Hickling; Alexia A Belperron; Linda K Bockenstedt; Jean I Tsao Journal: Ticks Tick Borne Dis Date: 2019-02-26 Impact factor: 3.744
Authors: Emma K Harris; Marisa R Harton; Maria Angela de Mello Marques; John T Belisle; Claudia R Molins; Nicole Breuner; Gary P Wormser; Robert D Gilmore Journal: Sci Rep Date: 2019-11-14 Impact factor: 4.379
Authors: Shannon L Delaney; Lilly A Murray; Claire E Aasen; Clair E Bennett; Ellen Brown; Brian A Fallon Journal: Front Med (Lausanne) Date: 2020-10-27